Lombard Odier Asset Management (USA)’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,500	Closed	-$1.88M	–	434
2022 Q4	$1.88M	Buy	+16,500	New	+$1.37M	0.05%	180
2020 Q4	–	Sell	-17,500	Closed	-$1.36M	–	351
2020 Q3	$1.36M	Hold	17,500	–	–	0.09%	168
2020 Q2	$973K	Buy	17,500 +2,500	+17%	+$107K	0.07%	181
2020 Q1	$444K	Buy	+15,000	New	+$507K	0.05%	167
2016 Q4	–	Sell	-600,000	Closed	-$10.9M	–	277
2016 Q3	$10.9M	Buy	600,000 +250,000	+71%	+$4.88M	1.01%	19
2016 Q2	$5.76M	Buy	350,000 +275,000	+367%	+$4.45M	0.7%	45
2016 Q1	$1.24M	Buy	+75,000	New	+$1.31M	0.17%	125
2014 Q3	–	Sell	-800,000	Closed	-$12.7M	–	246
2014 Q2	$12.7M	Buy	800,000 +150,000	+23%	+$2.14M	0.67%	38
2014 Q1	$9.83M	Buy	+650,000	New	+$7.34M	0.38%	76

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s HZNP Position: Q1 2023 in Review

Lombard Odier Asset Management (USA) sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q1 2023, closing a stake of 16,500 shares — an estimated $1.88M sold.

Lombard Odier Asset Management (USA) first reported a position in HZNP in Q1 2014 and held it in 9 quarters. The position peaked at $12.7M in Q2 2014. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Lombard Odier Asset Management (USA) reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q1 2023 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 16,500 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q1 2023, an estimated $1.88M.
Lombard Odier Asset Management (USA) first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2014 and held it in 9 quarters.
Lombard Odier Asset Management (USA)'s Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $12.7M in Q2 2014.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2023, filed 15 May 2023.